Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Price Target at $13.17

LifeMD, Inc. (NASDAQ:LFMD) has earned an average rating of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $13.1667.

Several research analysts have commented on LFMD shares. Lake Street Capital dropped their price objective on shares of LifeMD from $18.00 to $14.00 and set a “buy” rating for the company in a report on Wednesday, August 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of LifeMD in a report on Wednesday, October 8th. Zacks Research raised shares of LifeMD from a “strong sell” rating to a “hold” rating in a report on Friday, September 5th. KeyCorp lowered their price target on shares of LifeMD from $14.00 to $12.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Finally, HC Wainwright lowered their price target on shares of LifeMD from $14.00 to $13.00 and set a “buy” rating for the company in a report on Thursday, August 7th.

LifeMD Stock Up 1.1%

LFMD opened at $6.30 on Friday. The firm has a 50-day simple moving average of $6.32 and a two-hundred day simple moving average of $8.69. LifeMD has a 52 week low of $3.99 and a 52 week high of $15.84. The company has a market capitalization of $298.75 million, a PE ratio of -30.00 and a beta of 1.67. The company has a quick ratio of 0.72, a current ratio of 0.77 and a debt-to-equity ratio of 9.21.

Insider Activity at LifeMD

In related news, insider Nicholas P. Alvarez sold 75,000 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $5.92, for a total value of $444,000.00. Following the completion of the transaction, the insider owned 605,000 shares of the company’s stock, valued at approximately $3,581,600. This trade represents a 11.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 18.40% of the company’s stock.

Institutional Trading of LifeMD

Several institutional investors have recently added to or reduced their stakes in LFMD. GAMMA Investing LLC bought a new stake in LifeMD in the first quarter worth about $35,000. CWM LLC increased its position in shares of LifeMD by 17.5% during the first quarter. CWM LLC now owns 9,050 shares of the company’s stock worth $49,000 after acquiring an additional 1,351 shares during the period. Nisa Investment Advisors LLC increased its position in shares of LifeMD by 148.5% during the second quarter. Nisa Investment Advisors LLC now owns 3,656 shares of the company’s stock worth $50,000 after acquiring an additional 2,185 shares during the period. Tower Research Capital LLC TRC increased its position in shares of LifeMD by 110.4% during the second quarter. Tower Research Capital LLC TRC now owns 4,674 shares of the company’s stock worth $64,000 after acquiring an additional 2,452 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of LifeMD by 1,004.9% during the second quarter. Caitong International Asset Management Co. Ltd now owns 5,171 shares of the company’s stock worth $70,000 after acquiring an additional 4,703 shares during the period. Institutional investors own 35.52% of the company’s stock.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.